Pharmaceutical Industry discussion, review, analysis, news and information. |
« China Biopharmaceuticals Completed All Clinical Trials for Nafamostate Mesilate | Main | ABILIFY® DISCMELT™(aripiprazole): New Rapidly Disintegrating Oral Form of Antipsychotic Medication ABILIFY® (aripiprazole), Launched by Bristol-Myers Squib Co. and Otsuka Pharma Co. »
|
Aug22
|
 SPCT evaluates the physiological and behavioral impact of such high value targets by utilizing a battery of more than 85 pharmacologically-validated challenge or bioassays (measuring over 400 individual parameters), and covering most therapeutic areas. The financial terms of the deal were not disclosed. Source: Caliper Life Sciences |
TrackBack URL for this entry:
« China Biopharmaceuticals Completed All Clinical Trials for Nafamostate Mesilate | Main | ABILIFY® DISCMELT™(aripiprazole): New Rapidly Disintegrating Oral Form of Antipsychotic Medication ABILIFY® (aripiprazole), Launched by Bristol-Myers Squib Co. and Otsuka Pharma Co. »
Use these fast growing business social media sites to promote your business, feature your products, spotlight your business leaders, create links, and drive traffic back to your company site, all for free!
BIZZlogos - Add your logo - free link to your site| View Network Map Network Feed List (OPML) Know More Media Network Feed |
PharmaGazette is a member of the Know More Media network of business related blogs.
Here are some current headlines from some of our business publications:
ProductivityGoal | CallCenterScript |
AdHurl | TheBizofKnowledge |
LandingTheDeal | CustomersAreAlways |
HealthCareVox | BrainBasedBusiness |
TheInsurancePolicy | MarketingBlurb |
Write for us About us Contact Advertise Privacy Disclaimer
This weblog is licensed under a Creative Commons License.
Comment Preview